Skip to main content
. 2014 Jul 15;7(8):5016–5023.

Figure 3.

Figure 3

Kaplan-Meier survival curves illustrating the significance of DEK expression in SCLC in relation to clinical stage. In late-stage SCLC, patients with DEK high-level expression had lower disease-free (A) and 5-year survival (B) rates than those with DEK low-level expression (P = 0.002 and P = 0.001, respectively). In early-stage SCLC, disease-free (C) and 5-year survival (D) rates did not correlate with DEK expression status (P = 0.238 and P = 0.246).